| 2024-11-14 |
详情>>
股本变动：
变动后总股本452.27万股
|
| 2024-11-14 |
详情>>
业绩披露：
2024年三季报(累计)每股收益-5.06美元,归母净利润-1612.6万美元,同比去年增长85.16%
|
| 2024-11-14 |
财报披露：
美东时间 2024-11-14 盘后发布财报
|
| 2024-10-23 |
股东大会：
将于2024-11-13召开股东大会
会议内容 ▼▲
- 1.To authorize, for purposes of complying with Nasdaq Listing Rule 5635(d), the issuance of shares of common stock, in an amount equal to or in excess of 20% of the common stock outstanding as of March 12, 2024, underlying:warrants issued or to be issued by the Company pursuant to that certain Convertible Notes Purchase Agreement, dated as of August 12, 2024, by and among the Company and certain institutional and accredited investors (the “Note Purchase Agreement”) (“Proposal 1A”);warrants amended by those certain Amendments to Common Stock Purchase Warrants dated as of August 15, 2024, by and between the Company and the institutional investors party to that certain Convertible Notes Exchange Agreement, dated as of August 12, 2024 (the “Note Exchange Agreement”) (“Proposal 1B”);certain of the Company’s 11.00% / 13.00% Convertible Senior Secured Notes due 2028 issued or to be issued pursuant to the Note Purchase Agreement and the Note Exchange Agreement (“Proposal 1C”);
2.To approve an amendment and restatement of the Company’s 2018 Equity Incentive Plan to increase the number of shares authorized for issuance by 1,850,000 shares and to extend the plan term (“Proposal 2”);
3.To approve an adjournment of the Special Meeting, if necessary or appropriate, to solicit additional proxies (“Proposal 3”);
4.To transact any other matters that may properly come before the Special Meeting or any adjournments or postponements thereof.
|
| 2024-10-18 |
复牌提示：
2024-10-17 19:50:00 停牌，复牌日期 2024-10-18 09:00:00
|
| 2024-10-18 |
详情>>
拆分方案：
每10.0000合并分成1.0000股
|
| 2024-09-16 |
股东大会：
将于2024-10-09召开股东大会
会议内容 ▼▲
- 1.To approve an amendment to our Certificate of Incorporation to effect a reverse stock split of our common stock at a reverse stock split ratio ranging from 3:1 to 15:1, inclusive (“Proposal 1”);
2.To approve an amendment to our Certificate of Incorporation to effect a reduction in the total number of authorized shares of our common stock as illustrated in the table under the caption “Relationship Between the Reverse Stock Split Ratio and the Authorized Shares Reduction” (which is conditioned on approval and implementation of Proposal 1) (“Proposal 2”);
3.To approve an adjournment of the Special Meeting, if necessary or appropriate, to solicit additional proxies (“Proposal 3”);
4.To transact any other matters that may properly come before the Special Meeting or any adjournments or postponements thereof.
|
| 2024-08-12 |
详情>>
业绩披露：
2024年中报每股收益0.07美元,归母净利润227.60万美元,同比去年增长106.46%
|
| 2024-05-15 |
详情>>
业绩披露：
2024年一季报每股收益-0.14美元,归母净利润-418.9万美元,同比去年增长75.98%
|
| 2024-04-24 |
股东大会：
将于2024-06-05召开股东大会
会议内容 ▼▲
- 1.To elect the six director nominees named in the Proxy Statement to serve until the 2025 Annual Meeting of Stockholders or until their successors are duly elected and qualified;
2.To ratify the selection of KPMG LLP as the Company’s independent registered public accounting firm for the year ending December 31, 2024;
3.To approve an amendment to the Company’s Certificate of Incorporation to increase the number of authorized shares of the Company’s common stock, par value $0.001 per share (the “common stock”), from 164,000,000 to 300,000,000;
4.To authorize, for purposes of complying with Nasdaq Listing Rule 5635(d), the issuance of shares of common stock underlying certain warrants issued by the Company pursuant to that certain Securities Purchase Agreement, dated as of March 31, 2024, by and among the Company and certain institutional and accredited investors, and those certain Warrant Amendment Agreements, dated as of March 31, 2024, by and between the Company and the institutional investors participating in the offering, in an amount equal to or in excess of 20% of the common stock outstanding immediately prior the issuance of such warrants;
5.To transact any other matters that may properly come before the Annual Meeting or any adjournments or postponements thereof.
|
| 2024-04-01 |
详情>>
业绩披露：
2023年年报每股收益-7.87美元,归母净利润-1.24亿美元,同比去年增长-225.27%
|
| 2023-11-13 |
详情>>
业绩披露：
2023年三季报(累计)每股收益-8.54美元,归母净利润-1.09亿美元,同比去年增长-344.86%
|
| 2023-08-14 |
详情>>
业绩披露：
2023年中报每股收益-3.01美元,归母净利润-3524.8万美元,同比去年增长-82.43%
|
| 2023-05-15 |
详情>>
业绩披露：
2023年一季报每股收益-1.59美元,归母净利润-1744.1万美元,同比去年增长-26.31%
|
| 2023-04-27 |
股东大会：
将于2023-06-14召开股东大会
会议内容 ▼▲
- 1.To elect the six director nominees named in the Proxy Statement to serve until the 2024 Annual Meeting of Stockholders or until their successors are duly elected and qualified;
2.To approve an amendment and restatement of our 2018 Equity Incentive Plan, including an increase of 5,500,000 shares reserved for issuance thereunder;
3.To ratify the selection of KPMG LLP as the Company’s independent registered public accounting firm for the year ending December 31, 2023;
4.To transact any other matters that may properly come before the Annual Meeting or any adjournments or postponements thereof.
|
| 2023-03-30 |
详情>>
业绩披露：
2022年年报每股收益-5美元,归母净利润-3815.7万美元,同比去年增长84.58%
|
| 2023-01-03 |
详情>>
拆分方案：
每25.0000合并分成1.0000股
|
| 2022-11-29 |
股东大会：
将于2022-12-19召开股东大会
会议内容 ▼▲
- 1.To approve an amendment to our Certificate of Incorporation to effect a reverse stock split of our common stock at a reverse stock split ratio ranging from 5:1 to 25:1, inclusive (“Proposal 1”);
2.To approve an amendment to our Certificate of Incorporation to effect a reduction in the total number of authorized shares of our common stock as illustrated in the table under the caption “Relationship Between the Reverse Stock Split Ratio and the Authorized Shares Reduction” (“Proposal 2”);
3.To approve an adjournment of the Special Meeting, if necessary or appropriate, to solicit additional proxies (“Proposal 3”);
4.To transact any other matters that may properly come before the Special Meeting or any adjournments or postponements thereof.
|
| 2022-11-14 |
详情>>
业绩披露：
2022年三季报(累计)每股收益-0.13美元,归母净利润-2443.5万美元,同比去年增长84.19%
|
| 2022-08-15 |
详情>>
业绩披露：
2022年中报每股收益-0.1美元,归母净利润-1932.1万美元,同比去年增长82.56%
|
| 2022-04-28 |
股东大会：
将于2022-06-15召开股东大会
会议内容 ▼▲
- 1.To elect the seven director nominees named in the Proxy Statement to serve until the 2023 Annual Meeting of Stockholders or until their successors are duly elected and qualified;
2.To ratify the selection of KPMG LLP as the Company’s independent registered public accounting firm for the year ending December 31, 2022;
3.To transact any other matters that may properly come before the Annual Meeting or any adjournments or postponements thereof.
|
| 2021-06-16 |
股东大会：
将于2021-06-14召开股东大会
会议内容 ▼▲
- 1.To elect the seven director nominees named in the Proxy Statement to serve until the 2022 Annual Meeting of Stockholders or until their successors are duly elected and qualified (“Proposal 1”);
2.To ratify the selection of KPMG LLP as the Company’s independent registered public accounting firm for the year ending December 31, 2021 (“Proposal 2”);
3.To transact any other matters that may properly come before the Annual Meeting or any adjournments or postponements thereof.
|
| 2021-04-15 |
股东大会：
将于2021-06-02召开股东大会
会议内容 ▼▲
- 1.To elect the seven director nominees named in the Proxy Statement to serve until the 2022 Annual Meeting of Stockholders or until their successors are duly elected and qualified (“Proposal 1”);
2.To ratify the selection of KPMG LLP as the Company’s independent registered public accounting firm for the year ending December 31, 2021 (“Proposal 2”);
3.To transact any other matters that may properly come before the Annual Meeting or any adjournments or postponements thereof.
|
| 2020-06-19 |
详情>>
内部人交易：
Stylli Harry共交易3笔
|